North America Western Blotting Market Outlook (2019–2027)
The North America western blotting market is projected to grow from US$ 257.05 million in 2018 to US$ 404.96 million by 2027, registering a CAGR of 5.4% during the forecast period (2019–2027).
Market Drivers
The market growth is primarily driven by increasing investments in proteomic research and the rising prevalence of Lyme disease and HIV. However, the emergence of alternative protein detection technologies is expected to pose a challenge to the market’s expansion.
📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00006462
Western blotting remains a gold standard in diagnostic testing and research due to its high specificity and ability to deliver confirmatory results. In North America, Lyme disease—a tick-borne illness—is increasingly prevalent, largely attributed to climate change. A 2018 study by Carnegie Mellon University highlights the growing incidence of Lyme disease in the United States. Western blot IgM testing has shown a specificity of 94–96% in patients exhibiting clinical symptoms, reinforcing its role in accurate diagnosis.
Similarly, the continued global rise in HIV/AIDS cases contributes to the growing use of western blotting. HIV attacks the immune system, leading to acquired immunodeficiency syndrome (AIDS), a potentially life-threatening condition. As reported by the US Department of Health & Human Services in 2017, around 36.9 million people worldwide were living with HIV/AIDS, with most cases occurring in low- and middle-income countries. In India, the estimated HIV prevalence in 2017 was 0.22%, with adult prevalence rates of 0.25% in males and 0.19% in females. Western blotting is commonly used as a confirmatory test following ELISA screening in HIV diagnostics, and it has historically been regarded as the gold standard for HIV-1 diagnosis. In 2016 alone, HIV.gov reported approximately 38,700 new HIV infections in the US, underlining the continued demand for reliable diagnostic tools.
Regional Insights
The United States is expected to dominate the North American market throughout the forecast period. This leadership is supported by ongoing advancements in biotechnology, robust R&D initiatives in diagnostics, and the country’s position as a major exporter of biotechnology-derived agricultural products. These factors are anticipated to significantly contribute to the market’s growth in the US, which is poised to hold the largest share within the North American region.
Strategic Insights: North America Western Blotting Market
Strategic insights into the North America Western Blotting market offer a data-driven analysis of industry dynamics, highlighting key trends, competitive landscapes, and regional distinctions. These insights empower stakeholders—whether investors, manufacturers, or innovators—to identify emerging opportunities, differentiate through unique value propositions, and capitalize on untapped market segments.
By leveraging advanced analytics, these insights provide a forward-looking view of market evolution, enabling players to anticipate changes and adapt proactively. In a rapidly evolving landscape, this strategic foresight is critical to sustaining long-term growth, enhancing profitability, and achieving business objectives.
Ultimately, these insights serve as a catalyst for informed decision-making and strategic positioning, ensuring stakeholders remain agile and competitive in the North American Western Blotting market.
Market leaders and key company profiles
Thermo Fisher Scientific Inc.
Merck KGaA,
GENERAL ELECTRIC
Cell Signaling Technology, Inc.
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
LI-COR, Inc.
OriGene Technologies, Inc.,
Rockland Immunochemicals Inc.
Abcam plc
North America Western Blotting Regional Insights
The geographic scope of the North America Western Blotting refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Can you see this our reports
North America Medical Laser Systems Market – https://postyourarticle.com/north-america-medical-laser-systems-market-trends-size-segment-and-growth-by-forecast-to-2030-3/
Europe Railway Cyber Security Market – https://github.com/businessmarketinsights985/business-market-insights/issues/77
Europe Antibiotics Market – https://sites.google.com/view/businessmarketinsights21/home
Europe Wet Pet Food Market – https://businessmarketins02.blogspot.com/2025/05/europe-wet-pet-food-market-trends-size_15.html
North America Dropshipping Market – https://www.linkedin.com/feed/update/urn:li:activity:7328770680928231425?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFoU1YcBnRwRNJ26KRFoU-JXA3i-VZNmbCk
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
